| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.2 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |